Harvard Health Letter

Are the new migraine medications working?

Are the new migraine medications working? Doctors say three recently approved migraine prevention drugs are helping people have fewer headaches. For people with frequent, debilitating migraine headaches, 2018 brought encouraging news. The FDA approved three new medications erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality) the first drugs designed specifically to prevent migraines and reduce their frequency, intensity, and duration. …

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In